Per the U.S. DoD, * Indicates a "small business" classification and ** indicates a "small disadvantaged business". NOTE: the U.S. DoD only publicly reports contracts valued at $6.5 million USD or greater. The contract language is EXACTLY as it appears on the official U.S. DoD website (http://www.defense.gov/contracts/) unless otherwise noted.
Principle Contractor: MediVector, Incorporated
Date Reported: 3/12/2012
Department: Defense Threat Reduction Agency
Contract Details: MediVector, Inc., Boston, Mass., is being awarded a $138,500,000 cost-plus-fixed-fee contract for advance development of emerging infectious diseases medical countermeasure drug for the Federal Drug Administration licensure. Work will be performed in Boston, Mass., and is expected to be completed April 2016. Contract funds will not expire at the end of the current fiscal year. Solicitation was issued for full and open competition and four proposals were received. The Defense Threat Reduction Agency, Fort Belvoir, Va., is the contracting activity (HDTRA1-12-C-0031).
Total Contract Value: $138,500,000
View More Contracts by MediVector, Incorporated